TNFSF13B and systemic lupus erythematosus: Therapeutic interventions for SLE include Peroxisome Proliferator-Activated Receptor (PPAR)-γ agonism (pioglitazone) and type 1 Interferon receptor (anifrolumab) or B cell-activating factor (BAFF) blockade.